Impact of spironolactone on vascular, myocardial, and functional parameters in untreated patients with a hypertensive response to exercise

American Journal of Hypertension

Volumn 26, Issue 5, 2013, Pages 691-699

  Hare, James L ^a,b   Sharman, James E ^a,c   Leano, Rodel ^a   Jenkins, Carly ^a   Wright, Leah ^a   Marwick, Thomas H ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

Author keywords

aldosterone antagonist; blood pressure; echocardiography; exercise; hypertension; left ventricular hypertrophy

Indexed keywords

PLACEBO; SPIRONOLACTONE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSIVE RESPONSE TO EXERCISE; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; MEDICAL HISTORY; PREVALENCE; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREADMILL ERGOMETRY;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE; FEMALE; HEART; HEART VENTRICLES; HUMANS; HYPERTENSION; MALE; MASKED HYPERTENSION; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PREVALENCE; PULSE WAVE ANALYSIS; SPIRONOLACTONE;

EID: 84876558675     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt008     Document Type: Article

References (33)

1. Sharabi Y, Ben-Cnaan R, Hanin A, Martonovitch G, Grossman E. The significance of hypertensive response to exercise as a predictor of hypertension and cardiovascular disease. J Hum Hypertens 2001; 15:353-356. (Pubitemid 32433030)
2. Manolio TA, Burke GL, Savage PJ, Sidney S, Gardin JM, Oberman A. Exercise blood pressure response and 5-year risk of elevated blood pressure in a cohort of young adults: the CARDIA study. Am J Hypertens 1994; 7:234-241. (Pubitemid 24110303)
3. Laukkanen JA, Kurl S, Rauramaa R, Lakka TA, Venalainen JM, Salonen JT. Systolic blood pressure response to exercise testing is related to the risk of acute myocardial infarction in middle-aged men. Eur J Cardiovasc Prev Rehabil 2006; 13:421-428. (Pubitemid 44318654)
4. Kjeldsen SE, Mundal R, Sandvik L, Erikssen G, Thaulow E, Erikssen J. Supine and exercise systolic blood pressure predict cardiovascular death in middle-aged men. J Hypertens 2001; 19:1343-1348. (Pubitemid 32730450)
5. Weiss SA, Blumenthal RS, Sharrett AR, Redberg RF, Mora S. Exercise blood pressure and future cardiovascular death in asymptomatic individuals. Circulation 2010; 121:2109-2116.
6. Mottram PM, Haluska B, Yuda S, Leano R, Marwick TH. Patients with a hypertensive response to exercise have impaired systolic function without diastolic dysfunction or left ventricular hypertrophy. J Am Coll Cardiol 2004; 43:848-853. (Pubitemid 38296487)
7. Sharman JE, Hare JL, Thomas S, Davies JE, Leano R, Jenkins C, Marwick TH. Association of masked hypertension and left ventricular remodeling with the hypertensive response to exercise. Am J Hypertens 2011; 24:898-903.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, the National High Blood Pressure Education Program Coordinating C. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42:1206-1252. (Pubitemid 37553153)
9. Tsiachris D, Tsioufis C, Dimitriadis K, Kokkinos P, Faselis C, Tousoulis D, Michaelides A, Papademetriou V, Stefanadis C. Relationship of ambulatory arterial stiffness index with blood pressure response to exercise in the early stages of hypertension. Blood Press Monit 2010; 15:132-138.
10. Warner JG Jr, Metzger DC, Kitzman DW, Wesley DJ, Little WC. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999; 33:1567-1572.
11. Mottram PM, Haluska B, Leano R, Cowley D, Stowasser M, Marwick TH. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 2004; 110:558-565. (Pubitemid 39031173)
12. Brilla CG, Matsubara LS, Weber KT. Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am J Cardiol 1993; 71:12A-16A. (Pubitemid 23046406)
13. Lim PO, Donnan PT, MacDonald TM. Aldosterone to renin ratio as a determinant of exercise blood pressure response in hypertensive patients. J Hum Hypertens 2001; 15:119-123. (Pubitemid 32170866)
14. Benetos A, Lacolley P, Safar ME. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1997; 17:1152-1156. (Pubitemid 27260336)
15. Lauer MS, Levy D, Anderson KM, Plehn JF. Is there a relationship between exercise systolic blood pressure response and left ventricular mass The Framingham Heart Study. Ann Intern Med 1992; 116:203-210.
16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463. (Pubitemid 41821197)
17. Burgess MI, Jenkins C, Sharman JE, Marwick TH. Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise. J Am Coll Cardiol 2006; 47:1891-1900.
18. Holland DJ, Sacre JW, McFarlane SJ, Coombes JS, Sharman JE. Pulse wave analysis is a reproducible technique for measuring central blood pressure during hemodynamic perturbations induced by exercise. Am J Hypertens 2008; 21:1100-1106.
19. Sharman JE, Lim R, Qasem AM, Coombes JS, Burgess MI, Franco J, Garrahy P, Wilkinson IB, Marwick TH. Validation of a generalized transfer function to noninvasively derive central blood pressure during exercise. Hypertension 2006; 47:1203-1208. (Pubitemid 44289180)
20. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605. (Pubitemid 44627304)
21. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens 2011; 24:52-58.
22. Plaksej R, Kosmala W, Frantz S, Herrmann S, Niemann M, Stork S, Wachter R, Angermann CE, Ertl G, Bijnens B, Weidemann F. Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure. J Hypertens 2009; 27:2483-2491.
23. Poulsen SH, Andersen NH, Heickendorff L, Mogensen CE. Relation between plasma amino-terminal propeptide of procollagen type III and left ventricular longitudinal strain in essential hypertension. Heart 2005; 91:624-629. (Pubitemid 40559353)
24. Kang SJ, Lim HS, Choi BJ, Choi SY, Hwang GS, Yoon MH, Tahk SJ, Shin JH. Longitudinal strain and torsion assessed by two-dimensional speckle tracking correlate with the serum level of tissue inhibitor of matrix metalloproteinase-1, a marker of myocardial fibrosis, in patients with hypertension. J Am Soc Echocardiogr 2008; 21:907-911.
25. Kohl HW 3rd, Nichaman MZ, Frankowski RF, Blair SN. Maximal exercise hemodynamics and risk of mortality in apparently healthy men and women. Med Sci Sports Exerc 1996; 18:601-609. (Pubitemid 26137895)
26. Kato S, Onishi K, Yamanaka T, Takamura T, Dohi K, Yamada N, Wada H, Nobori T, Ito M. Exaggerated hypertensive response to exercise in patients with diastolic heart failure. Hypertens Res 2008; 31:679-684. (Pubitemid 351772859)
27. Gottdiener JS, Brown J, Zoltick J, Fletcher RD. Left ventricular hypertrophy in men with normal blood pressure: relation to exaggerated blood pressure response to exercise. Ann Intern Med 1990; 112:161.
28. Wilson MF, Sung BH, Pincomb GA, Lovallo WR. Exaggerated pressure response to exercise in men at risk for systemic hypertension. Am J Cardiol 1990; 66:731-736. (Pubitemid 20285117)
29. Stewart KJ, Sung J, Silber HA, Fleg JL, Kelemen MD, Turner KL, Bacher AC, Dobrosielski DA, DeRegis JR, Shapiro EP, Ouyang P. Exaggerated exercise blood pressure is related to impaired endothelial vasodilator function. Am J Hypertens 2004; 17:314-320. (Pubitemid 38446845)
30. Sharman JE, McEniery CM, Dhakam ZR, Coombes JS, Wilkinson IB, Cockcroft JR. Pulse pressure amplification during exercise is significantly reduced with age and hypercholesterolemia. J Hypertens 2007; 25:1249-1254. (Pubitemid 46918804)
31. Wilkinson IB, Prasad K, Hall IR, Thomas A, MacCallum H, Webb DJ, Frenneaux MP, Cockcroft JR. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol 2002; 39:1005-1011. (Pubitemid 34234123)
32. Sciarretta S, Paneni F, Palano F, Chin D, Tocci G, Rubattu S, Volpe M. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. Clin Sci (Lond) 2009; 116:467-477.
33. Mahmud A, Feely J. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. Am J Hypertens 2005; 18:50-55. (Pubitemid 40187349)